
Logo of National Cancer Institute from commons.wikimedia.org
Jun 24, 2024, 01:23
Key regulatory changes that occur with common neuroblastoma therapy – National Cancer Institute
National Cancer Institute shared a post on X:
“Investigators at the NCI Center for Cancer Research have mapped key regulatory changes that occur when a common neuroblastoma therapy, retinoic acid, drives tumor cells to develop into neurons, thereby curbing their growth. Learn more.”
Source: National Cancer Institute/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19